Marijuana reform opponents are asking a federal court not to let two medical cannabis companies intervene in a lawsuit that seeks to block the Trump administration from moving forward with federally rescheduling the drug.
The businesses—MedPharm Iowa, LLC, which does business as Bud & Mary’s, and Tri-Mountain Pure, LLC—moved late last month to join the side of the government in opposing the litigation from prohibitionists.
But now, in two separate filings, anti-rescheduling groups that brought legal challenges that have since been consolidated are arguing that the firms should not be allowed to take part in the litigation.
Lawyers for Smart Approaches to Marijuana (SAM) and National Drug and Alcohol Screening Association (NDASA) wrote in a brief that the marijuana companies “have not identified any argument they would make that would not be pressed by the government” and, as such, “are not entitled to intervention.”
“The motion to intervene should be denied because…they have not shown that the government will not adequately represent their interests in this case,” it says.
“Proposed Intervenors fail to demonstrate that their interests diverge from the government’s in any way or that their presentations in the case will differ at all from the government’s. They do
Read full article on Marijuana Moment
